Regencell Bioscience Holdings (RGC) Price to Book (2022 - 2025)

Regencell Bioscience Holdings (RGC) has reported Price to Book for 4 consecutive years, with 224.11 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Price to Book changed N/A year-over-year to 224.11; the trailing twelve-month figure through Dec 2025 stood at 224.11 (changed N/A YoY), and the FY2025 full-year result was 45.62, up 32495.65% from the prior year.
• Price to Book improved to 224.11 in Q4 2025 per RGC's latest filing, from 45.62 in the prior quarter.
• Across five years, Price to Book topped out at 224.11 in Q4 2025 and bottomed at 0.14 in Q2 2024.
• Historically, Price to Book has averaged 54.24 across 4 years, with a median of 0.69 in 2022.
• The sharpest annual moves came in 2024 and 2025: Price to Book sank 78.73% in 2024, then jumped 32495.65% in 2025.
• Over 4 years, Price to Book stood at 0.69 in 2022, then declined by 5.15% to 0.66 in 2023, then tumbled by 78.73% to 0.14 in 2024, then surged by 160014.25% to 224.11 in 2025.
• According to Business Quant data, Price to Book over the past three periods registered 224.11, 45.62, and 0.14 for Q4 2025, Q2 2025, and Q2 2024 respectively.